Maitake (Grifola frondosa)

Mushroomimmune mushroomModerate dose evidence

Also known as: Grifola frondosa, hen of the woods, hen-of-the-woods, D-fraction, MD-fraction, maitake mushroom

Add to a formula

Maitake is a clustered, edible polypore whose proprietary beta-glucan extract, D-fraction, has been studied in small oncology and immunology trials, including a phase II study in myelodysplastic syndromes. A 2026 randomized trial in healthy older Japanese adults examined cognitive outcomes with maitake supplementation. Supplements use a hot-water extract of the fruiting body standardized to beta-glucans, and maitake is a frequent component of immune and blood-sugar-support mushroom blends. Its beta-glucans are highly branched, which is often cited as the reason it is favored for immune formulas.

Research summary

Highly branched beta-1,6/1,3-glucans (D-fraction) are studied for macrophage and natural killer cell activation; other fractions are studied for effects on glucose metabolism.

Dosage

Daily amounts, of extract.

Lowest studiedTypical rangeHighest studiedUpper limit
500 mg500–2,000 mg

Take 0.5–2 g of extract daily with food. D-fraction studies dosed by beta-glucan content rather than crude extract, so match doses by standardized beta-glucan when substituting between suppliers. Users on blood-sugar-lowering medication should be cautioned.

Standardization: ≥20% beta-glucans

Source material: fruiting body

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Mild, earthy taste; blends well in mushroom complexes.

Formulation notes

Studied for effects on glucose; may add to blood-sugar-lowering drugs.

Sources

  1. Maitake Mushroom (Grifola frondosa) Enhances Cognitive Function in Healthy Older Japanese: A Randomized, Double-Blind, Placebo-Controlled Trial. (Jogi 2026)PubMed
  2. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. (Wesa 2015)PubMed

Related ingredients